Nifty
Sensex
:
:
14371.90
48878.54
-218.45 (-1.50%)
-746.22 (-1.50%)

Pharmaceuticals & Drugs - API

Rating :
62/99

BSE: 532815 | NSE: SMSPHARMA

114.55
22-Jan-2021
  • Open
  • High
  • Low
  • Previous Close
  •  114.20
  •  117.65
  •  114.15
  •  116.20
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  85395
  •  98.46
  •  129.80
  •  24.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 972.65
  • 30.30
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,112.33
  • 0.22%
  • 2.65

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 67.29%
  • 2.23%
  • 26.35%
  • FII
  • DII
  • Others
  • 0.56%
  • 0.00%
  • 3.57%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.02
  • -7.60
  • -3.95

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.51
  • -2.15
  • -3.03

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.57
  • -4.72
  • -6.85

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.15
  • 18.19
  • 16.90

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.95
  • 2.07
  • 1.71

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.27
  • 8.66
  • 7.45

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
130.13
117.90
10.37%
112.90
117.14
-3.62%
96.47
103.71
-6.98%
80.45
101.25
-20.54%
Expenses
106.46
95.68
11.27%
91.45
93.73
-2.43%
82.05
88.07
-6.84%
60.44
75.66
-20.12%
EBITDA
23.67
22.22
6.53%
21.44
23.41
-8.42%
14.42
15.64
-7.80%
20.01
25.59
-21.81%
EBIDTM
18.19%
18.85%
18.99%
19.98%
14.01%
14.01%
24.88%
25.28%
Other Income
0.92
0.58
58.62%
0.81
0.65
24.62%
3.09
0.75
312.00%
0.79
0.59
33.90%
Interest
2.72
2.99
-9.03%
2.95
3.42
-13.74%
2.87
3.18
-9.75%
2.93
2.72
7.72%
Depreciation
5.61
5.38
4.28%
5.49
5.30
3.58%
6.00
4.87
23.20%
5.38
4.83
11.39%
PBT
16.25
14.42
12.69%
13.81
15.34
-9.97%
8.63
8.33
3.60%
12.50
18.64
-32.94%
Tax
5.03
4.87
3.29%
4.61
5.86
-21.33%
2.38
1.86
27.96%
5.00
6.45
-22.48%
PAT
11.23
9.55
17.59%
9.20
9.48
-2.95%
6.25
6.47
-3.40%
7.50
12.19
-38.47%
PATM
8.63%
8.10%
8.15%
8.09%
7.11%
7.11%
9.32%
12.04%
EPS
1.30
1.17
11.11%
0.83
0.92
-9.78%
28.29
28.29
0.00%
0.90
1.11
-18.92%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 07
Net Sales
419.95
411.95
464.91
464.93
445.49
611.53
199.84
Net Sales Growth
-4.56%
-11.39%
0.00%
4.36%
-27.15%
206.01%
 
Cost Of Goods Sold
4,839.86
246.36
292.71
289.90
295.85
385.15
109.95
Gross Profit
-4,419.91
165.59
172.20
175.03
149.64
226.38
89.88
GP Margin
-1,052.49%
40.20%
37.04%
37.65%
33.59%
37.02%
44.98%
Total Expenditure
340.40
331.92
374.77
371.59
370.35
522.32
150.38
Power & Fuel Cost
-
18.99
21.75
22.57
18.23
33.81
8.95
% Of Sales
-
4.61%
4.68%
4.85%
4.09%
5.53%
4.48%
Employee Cost
-
39.35
35.59
32.80
26.92
38.11
5.81
% Of Sales
-
9.55%
7.66%
7.05%
6.04%
6.23%
2.91%
Manufacturing Exp.
-
14.89
13.29
12.14
10.35
37.94
7.31
% Of Sales
-
3.61%
2.86%
2.61%
2.32%
6.20%
3.66%
General & Admin Exp.
-
8.05
8.69
8.45
9.00
10.51
3.36
% Of Sales
-
1.95%
1.87%
1.82%
2.02%
1.72%
1.68%
Selling & Distn. Exp.
-
3.70
2.25
4.81
9.67
15.99
10.41
% Of Sales
-
0.90%
0.48%
1.03%
2.17%
2.61%
5.21%
Miscellaneous Exp.
-
0.58
0.49
0.91
0.33
0.80
4.59
% Of Sales
-
0.14%
0.11%
0.20%
0.07%
0.13%
2.30%
EBITDA
79.54
80.03
90.14
93.34
75.14
89.21
49.46
EBITDA Margin
18.94%
19.43%
19.39%
20.08%
16.87%
14.59%
24.75%
Other Income
5.61
5.11
3.40
2.39
1.45
3.61
3.03
Interest
11.47
12.32
11.92
15.48
15.82
17.11
8.23
Depreciation
22.48
22.07
19.27
19.90
19.18
19.43
4.58
PBT
51.19
50.76
62.35
60.35
41.58
56.27
39.67
Tax
17.02
18.07
20.90
19.89
5.97
14.63
14.20
Tax Rate
33.25%
35.60%
33.52%
32.96%
14.36%
26.00%
35.80%
PAT
34.18
32.69
41.45
40.45
35.61
41.64
25.47
PAT before Minority Interest
34.18
32.69
41.45
40.45
35.61
41.64
25.47
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
8.14%
7.94%
8.92%
8.70%
7.99%
6.81%
12.75%
PAT Growth
-9.31%
-21.13%
2.47%
13.59%
-14.48%
63.49%
 
EPS
4.04
3.86
4.89
4.78
4.20
4.92
3.01

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 07
Shareholder's Funds
348.24
321.92
284.49
254.74
293.60
192.08
Share Capital
8.47
8.47
8.47
8.47
8.47
10.00
Total Reserves
339.77
313.45
276.02
246.28
285.14
182.07
Non-Current Liabilities
114.47
94.35
96.58
91.41
161.56
88.21
Secured Loans
67.02
61.01
70.20
73.02
109.58
65.92
Unsecured Loans
1.20
1.20
1.20
1.20
3.64
6.95
Long Term Provisions
1.73
1.52
2.18
1.35
3.43
0.00
Current Liabilities
154.21
156.05
134.29
156.00
200.43
49.03
Trade Payables
44.49
47.70
39.27
66.75
84.40
23.86
Other Current Liabilities
38.84
23.32
22.91
19.95
40.37
0.33
Short Term Borrowings
61.16
70.81
58.40
59.76
72.75
0.00
Short Term Provisions
9.72
14.22
13.71
9.54
2.90
24.84
Total Liabilities
616.92
572.32
515.36
502.15
655.59
329.32
Net Block
280.49
281.26
279.26
290.45
370.35
68.84
Gross Block
360.77
339.57
318.34
309.63
500.81
96.16
Accumulated Depreciation
80.29
58.31
39.08
19.18
130.46
27.32
Non Current Assets
389.13
351.22
334.04
335.80
408.04
83.85
Capital Work in Progress
42.12
18.30
8.20
7.76
12.80
15.02
Non Current Investment
25.81
26.99
28.38
29.10
20.51
0.00
Long Term Loans & Adv.
38.47
22.55
16.19
6.58
4.37
0.00
Other Non Current Assets
2.25
2.13
2.01
1.90
0.00
0.00
Current Assets
227.78
221.09
181.32
166.36
247.55
233.89
Current Investments
0.00
0.00
0.00
0.00
0.00
0.03
Inventories
129.20
136.40
107.48
92.52
112.68
49.57
Sundry Debtors
48.77
26.02
24.15
21.32
61.09
59.98
Cash & Bank
9.65
14.88
12.71
12.37
15.08
95.71
Other Current Assets
40.16
26.73
22.09
28.48
58.70
28.60
Short Term Loans & Adv.
19.20
17.06
14.89
11.67
23.49
26.79
Net Current Assets
73.57
65.04
47.03
10.36
47.13
184.86
Total Assets
616.91
572.31
515.36
502.16
655.59
329.31

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 07
Cash From Operating Activity
39.71
49.76
31.81
73.47
61.22
14.33
PBT
50.76
62.35
60.35
41.58
56.27
39.67
Adjustment
28.66
26.81
31.08
31.58
28.14
18.09
Changes in Working Capital
-27.60
-26.02
-48.48
9.40
-1.17
-29.61
Cash after chg. in Working capital
51.82
63.14
42.95
82.56
83.24
28.16
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-12.10
-13.38
-11.14
-9.09
-22.02
-5.60
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-42.56
-34.67
-16.58
-38.96
-96.72
-31.70
Net Fixed Assets
-45.02
-31.33
-9.15
128.49
-346.44
Net Investments
0.00
0.00
-8.02
-15.71
-17.94
Others
2.46
-3.34
0.59
-151.74
267.66
Cash from Financing Activity
-2.40
-12.92
-14.89
-33.19
44.34
106.55
Net Cash Inflow / Outflow
-5.25
2.17
0.35
1.32
8.84
89.18
Opening Cash & Equivalents
14.80
12.63
12.29
11.25
2.41
6.53
Closing Cash & Equivalent
9.54
14.80
12.63
12.29
11.25
95.71

Financial Ratios

Standalone /

Consolidated
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 07
Book Value (Rs.)
41.14
38.03
33.61
30.09
34.68
18.05
ROA
5.50%
7.62%
7.95%
6.15%
8.46%
7.73%
ROE
9.76%
13.67%
15.00%
12.99%
17.57%
14.11%
ROCE
13.06%
16.57%
18.17%
12.73%
19.54%
18.91%
Fixed Asset Turnover
1.29
1.53
1.59
1.12
2.11
2.24
Receivable days
30.27
18.23
16.66
33.12
35.09
101.66
Inventory Days
107.49
88.61
73.28
82.47
47.02
84.02
Payable days
46.62
40.24
46.81
71.90
36.96
57.46
Cash Conversion Cycle
91.14
66.60
43.12
43.69
45.14
128.22
Total Debt/Equity
0.44
0.45
0.51
0.59
0.70
0.40
Interest Cover
5.12
6.23
4.90
3.63
4.29
5.82

News Update:


  • SMS Pharmaceuticals - Quarterly Results
    3rd Nov 2020, 14:50 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.